FDA claims victory with “Elsa” AI tool launch, but insiders call it half-baked
The Food and Drug Administration has officially launched “Elsa,” a generative artificial intelligence platform designed to help staff across the agency work more efficiently. However, internal critics argue the rollout moved too quickly and say the tool, in its current state, is underwhelming.